“…For SARS‐CoV‐2 in solution in vitro, a 3‐log (99.9%) reduction in viral titer is predicted to occur in 12.5 h at the average temperature of upper airways (33°C), in 7.1 h at normal core body temperature (37°C), and in just 1.7 h at 45°C, an air temperature tolerable by healthy individuals for prolonged periods (95% confidence interval of 5.1–31.0, 2.8–17.7, and 0.6–4.6 h, respectively) (Figure 3). 3,93 Longer exposure to heat results in greater total reductions in viral decay. In addition to the possible effect on viral decay rates, warm air temperature and high relative humidity also facilitate a strong airway immune response, which could further contribute to the benefit of warm humidified air 21,33–38 …”